Dsrco B.V.

9 patents currently held · Updated Nov 14, 2026

1 more in force is now held by another company

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Aug 2027

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jun 19, 2027
The maintenance fee for Formulations and Methods for Direct Sodium Removal in Patients Having Heart Failure And/Or Severe Renal Dysfunction (US 11,844,890) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

Patent	Title	Status	Expires	Confidence
US 11,839,712	Implantable Fluid Management System for Treating Heart Failure In force Term ends Aug 21, 2027 · High confidence	In force	Term ends Aug 21, 2027	High confidence
US 8,202,248	Dialysis Implant and Methods of Use In force Term ends May 7, 2030 · High confidence	In force	Term ends May 7, 2030	High confidence
US 10,898,631	Direct Sodium Removal Method, Solution and Apparatus to Reduce Fluid Overload in Heart Failure Patients In force Term ends May 21, 2038 · High confidence	In force	Term ends May 21, 2038	High confidence
US 10,918,778	Direct Sodium Removal Method, Solution and Apparatus to Reduce Fluid Overload in Heart Failure Patients In force Term ends May 21, 2038 · High confidence	In force	Term ends May 21, 2038	High confidence
US 11,464,891	Implantable Pump for Direct Sodium Removal Therapy Having On-Board Analyte Sensor In force Term ends May 21, 2038 · Medium confidence	In force	Term ends May 21, 2038	Medium confidence
US 11,559,618	Formulations and Methods for Direct Sodium Removal in Patients Having Severe Renal Dysfunction In force Term ends May 21, 2038 · High confidence	In force	Term ends May 21, 2038	High confidence
US 11,602,583	Direct Sodium Removal Method, Solution and Apparatus to Reduce Fluid Overload in Heart Failure Patients In force Term ends May 21, 2038 · Low confidence	In force	Term ends May 21, 2038	Low confidence
US 11,844,890	Formulations and Methods for Direct Sodium Removal in Patients Having Heart Failure And/Or Severe Renal Dysfunction In force Term ends May 21, 2038 · High confidence	In force	Term ends May 21, 2038	High confidence
US 12,623,011	Implantable Pump for Direct Sodium Removal Therapy Having On-Board Analyte Sensor In force Term ends Sep 13, 2040 · Medium confidence	In force	Term ends Sep 13, 2040	Medium confidence

Also on record, not counted in the 9: 1 patent in force now held by others · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro